---
layout: archive
title: "Publications"
permalink: /publications/
author_profile: true
---

## Lab Publications

### Corresponding Author Studies

**Single-Cell Precision Medicine and Computational Methods**

* **Sinha, S.**, Vegesna, R., Mukherjee, S., et al. (2024). PERCEPTION predicts patient response and resistance to treatment using single-cell transcriptomics of their tumors. **Nature Cancer**, 1-15.

* Choudhary, M., Liu, L., Yadav, A., ... **Sinha, S.** (2024). ecPath detects ecDNA in tumors from histopathology images. **bioRxiv** doi: 10.1101/2024.11.13.623494 (Under revision in Nature).

* **Sinha, S.**, Sinha, N. and Ruppin, E., 2022. Deep characterization of cancer drugs mechanism of action by integrating large-scale genetic and drug screens. **Biorxiv**, pp.2022-10. (Revision in npj Precision Oncology)

### Cancer Disparities Research

* **Sinha, S.**, Mitchell, K.A., Zingone, A., Bowman, E., Sinha, N., Schäffer, A.A., Lee, J.S., Ruppin, E. and Ryan, B.M., 2020. Higher prevalence of homologous recombination deficiency in tumors from African Americans versus European Americans. **Nature Cancer**, 1(1), pp.112-121.

* Zingone, A., **Sinha, S.**, Ante, M., Nguyen, C., Daujotyte, D., Bowman, E.D., Sinha, N., Mitchell, K.A., et al., 2021. A comprehensive map of alternative polyadenylation in African American and European American lung cancer patients. **Nature Communications**, 12(1), p.5605.

* Mitchell, K.A., Nichols, N., Tang, W., Walling, J., Stevenson, H., Pineda, M., Stefanescu, R., Edelman, D.C., Girvin, A.T., Zingone, A. and **Sinha, S.**, 2019. Recurrent PTPRT/JAK2 mutations in lung adenocarcinoma among African Americans. **Nature Communications**, 10(1), p.5735.

### Genomic Editing & Cancer Mutations

* **Sinha, S.**, Barbosa, K., Cheng, K., Leiserson, M.D., Jain, P., Deshpande, A., Wilson III, D.M., Ryan, B.M., Luo, J., Ronai, Z.E.A. and Lee, J.S., 2021. A systematic genome-wide mapping of oncogenic mutation selection during CRISPR-Cas9 genome editing. **Nature Communications**, 12(1), p.6512.

### Patient Stratification Technologies

* Lee, J.S., Nair, N.U., Dinstag, G., Chapman, L., Chung, Y., Wang, K., **Sinha, S.**, Cha, H., Kim, D., et al., 2021. Synthetic lethality-mediated precision oncology via the tumor transcriptome. **Cell**, 184(9), pp.2487-2502.

* Ahmadi, S., Sukprasert, P., Vegesna, R., **Sinha, S.**, Schischlik, F., Artzi, N., Khuller, S., Schäffer, A.A. and Ruppin, E., 2022. The landscape of receptor-mediated precision cancer combination therapy via a single-cell perspective. **Nature Communications**, 13(1), p.1613.

* Hoang, D.T., Dinstag, G., Shulman, E.D., Hermida, L.C., Ben-Zvi, D.S., Elis, E., Caley, K., Sammut, S.J., **Sinha, S.**, Sinha, N. and Dampier, C.H., 2024. A deep-learning framework to predict cancer treatment response from histopathology images through imputed transcriptomics. **Nature Cancer**, 5(9), pp.1305-1317.

### Tumor Mutation Burden & Immunotherapy

* Sinha, N., **Sinha, S.**, Valero, C., Schäffer, A.A., Aldape, K., Litchfield, K., Chan, T.A., Morris, L.G. and Ruppin, E., 2022. Immune determinants of the association between tumor mutational burden and immunotherapy response across cancer types. **Cancer Research**, 82(11), pp.2076-2083.

* Sinha, N., **Sinha, S.**, Cheng, K., Madan, S., Erez, A., Ryan, B.M., Schäffer, A.A., Aldape, K. and Ruppin, E., 2021. Using a recently approved tumor mutational burden biomarker to stratify patients for immunotherapy may introduce a sex bias. **JCO Precision Oncology**, 5.

### Immunotherapy & Liquid Biopsies

* Cao, Y., Chang, T., Schischlik, F., Wang, K., **Sinha, S.**, Hannenhalli, S., Jiang, P. and Ruppin, E., 2023. Predicting tumor immune microenvironment and checkpoint therapy response of head & neck cancer patients from blood immune single-cell transcriptomics. **bioRxiv**, pp.2023-01.

* Wu, V.H., Yung, B.S., Faraji, F., Saddawi-Konefka, R., Wang, Z., Wenzel, A.T., Song, M.J., Pagadala, M.S., Clubb, L.M., Chiou, J. and **Sinha, S.**, 2023. The GPCR--Gαs--PKA signaling axis promotes T cell dysfunction and cancer immunotherapy failure. **Nature Immunology**, pp.1-13.

For a complete list of publications, please visit [Dr. Sinha's Google Scholar profile](https://scholar.google.com/citations?user=XXXXXXXXXXXX).
